Intelligence · Patents
Patents expiring in 2030
Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.
- Patents
- 880
Quick answer
880 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7777069
Prodrugs of carbamate inhibitors of IMPDH
granted -
US 7777019
Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
granted -
US 7776905
Modulators of ATP-binding cassette transporters
granted -
US 7781565
Compositions and methods related to profiling a plurality of cells based on peptide binding
granted -
US 7781577
Inhibitors of sodium glucose co-transporter 2 and methods of their use
granted -
US 7781448
Once daily dosage forms of trospium
granted -
US 7781478
Methods for treating hepatitis C
granted -
US 7781584
Dipeptidyl peptidase inhibitors
granted -
US 7781413
SEMA3B inhibits tumor growth and induces apoptosis in cancer cells
granted -
US 7781449
Trospium chloride treatment method
granted -
US 7781175
Method of screening compounds which alter the binding properties of GPR39, and homologs thereof, to bile acid
granted -
US 7781397
Human plasma hyaluronidase
granted -
US 7780963
Anti-ADDL antibodies and uses thereof
granted -
US 7780966
Artificial invaplex
granted -
US 7781404
IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof
granted -
US 7781445
Synthesis of indenoisoquinoliniums and methods of use
granted -
US 7786285
Recombinant vaccine against botulinum neurotoxin
granted -
US 7785565
Metal chelators and methods of their use
granted -
US 7786290
Double-stranded ribonucleic acid with increased effectiveness in an organism
granted -
US 7785597
VMP-like sequences of pathogenic Borrelia
granted -
US 7785806
Method for determining the immunogenicity of an antigen
granted -
US 7785886
Methods and reagents for modulating cholesterol levels
granted -
US 7784616
Dispenser for progestin used for acute maintenance treatment of DUB
granted -
US 7786080
Mutein of a bone morphogenetic protein and use thereof
granted -
US 7786091
Compositions and methods for ameliorating myosin VIIa defects
granted -
US 7786100
Composition and method of treating hearing loss
granted -
US 7786133
Chemically modified small molecules
granted -
US 7786136
Indazole-carboxamide compounds
granted -
US 7786141
Dihydrospiroindene modulators of muscarinic receptors
granted -
US 7786130
Pyridones useful as inhibitors of kinases
granted -
US 7786213
Biomacromolecule polymer conjugates
granted -
US 7786221
Multi-armed, monofunctional, and hydrolytically stable derivatives of poly (ethylene glycol) and related polymers for modification of surfaces and molecules
granted -
US 7786282
Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
granted -
US 7786308
Muscarinic modulators
granted -
US 7788045
Systems and method for homeostatic blood states
granted -
US 7786107
Modulators of muscarinic receptors
granted -
US 7786149
Thiadiazoles as CXC- and CC- chemokine receptor ligands
granted -
US 7786083
Metastin derivatives and use thereof
granted -
US 7786096
Inhibition of antigen presentation with poorly catabolized polymers
granted -
US 7786120
Pyridones useful as inhibitors of kinases
granted -
US 7786137
Bicyclic derivatives as modulators of ion channels
granted -
US 7786165
Aminophenylpropanoic acid derivative
granted -
US 7786316
Metalloprotein inhibitors
granted -
US 7790182
Protein vaccines against poxviruses
granted -
US 7790039
Tangential flow filtration devices and methods for stem cell enrichment
granted -
US 7790158
Methods for epitope-specific and cytokine/anticytokine combination immunotherapies
granted -
US 7790159
Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids
granted -
US 7790181
Live attenuated viral vaccines for Eastern Equine Encephalitis virus
granted
Frequently asked questions
How many pharma patents expire in 2030?
880 published patents in our USPTO index have expiration dates falling in calendar year 2030.